BID and hepatocellular carcinoma: In HBV-associated HCC, the downregulation of Bid levels mediated by the viral HBx protein desensitizes cells to extrinsic apoptotic stimuli, such as FasL and TNF-α, thereby promoting oncogenic transformation.